期刊文献+

肾素血管紧张素系统与糖尿病肾病相关性研究进展 被引量:5

下载PDF
导出
摘要 肾素血管紧张素系统是生理功能颇为复杂的内分泌系统,对糖尿病肾病的发生、发展有重要影响。目前由于糖尿病肾病(DN)所致终末期肾功能衰竭(ESRD),需行维持透析的患者数每年都在增加。为之耗费大量人力、物力、财力,可见对于DN发病机制和预防治疗的研究显得尤为重要。
机构地区 江西省人民医院
出处 《江西医药》 CAS 2008年第8期851-853,共3页 Jiangxi Medical Journal
  • 相关文献

参考文献13

  • 1Unger T.The ngiotensin type 2 receptor:Variations on enigmatic themes.J Hypertens,1997,17(12 Pt 2):1775
  • 2郑芬萍,李红.血管紧张素Ⅱ与糖尿病肾病的关系[J].国外医学(内分泌学分册),2002,22(1):19-21. 被引量:17
  • 3Jaffa A A,Chai K X,Chao J,et al.Reningene expression is altered by diabetes and insulin treatment (abstract).Clin Res, 1991,39:307A
  • 4Rippin J, Bain SC, Barnett AH. DETAIL study J.Rationale and design of diabetics exposed to telmisartan and enalapril (DETAIL) study.Diabetes Complications,2002,16(3):195
  • 5Brenner BM, Cooper ME, Zeeuw Dd Det al.The losartan renal protection study-rationale, study design and baseline characteristiesof RENAAL(reduction of endpoints in NIDDM with the angiotensin Ⅱ antagonist losartan).JRenin Angiotensin Aldosterone Syst,2000,1:328
  • 6EURODIAB controlled trial of lisinopril in IDDM.Effect of angiotensin converting enzyme (AEC) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDMpatients: Findings from the EUCLID Randomizes ControlledTrial.Diabetes, 1998,47:1507
  • 7施亚雄,郑善德.洛沙坦治疗早期糖尿病肾病的研究[J].中华内分泌代谢杂志,2000,16(4):235-238. 被引量:27
  • 8Houlihan CA,Akdeniz A,Tsalamandris C,et al.Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: Effectsof angiotensin receptor blockade and sodium restriction.Diabetes Care,2002,;25 (6): 1072
  • 9Agarwal R,Siva S,Dunn SRet al.Add-on angiotensin Ⅱ Receptor blockade lowersurinarytransforminggrowth factor-beta levels.AmJKidney Dis,2002,39(3):486
  • 10Rippin J,Bain SC,Barnett AH.DETAIL study J.Rationale and design of diabetics exposed to telmisartan and enalapril (DETAIL) study.Diabetes Complieations,2002 ,16(3):195

二级参考文献18

  • 1Chan J C,Am J Nephrol,1997年,17卷,72页
  • 2Mizuiri S,Yoshikawa H,Tanegashima M,et al.Renal ACE immunohistochemical location in NIDDM patients with nephropathy[J].Am J Kidney,1998,31:301-307.
  • 3Lai K N,Leung J C,Lai K B,et al.Gene expression of the renin-angiotensin system in human kidney[J].J Hypertens,1998,16:91-102.
  • 4Wagner J,Gehlen F,Ciechanowicz A,et al.Angiotensin Ⅱ receptor typeⅠgene expression in human glomerulonephritis and diabetes mellitus[J].J Am Soc Nephrol,1999,10:545-551.
  • 5Leehey D J,Singh A K,Alavi N,et al.Role of angiotensin Ⅱ in DN[J].Kidney Int,2000,58:s93-s98.
  • 6Thaiss F,Wolf G,Assad N,et al.Angiotensinase A gene expression and enzyme activity in isolated glomeruli of diabetic rats[J].Diabetologia,1996,39:275-280.
  • 7Hirano T,Kashiwazaki K,Moritomo Y,et al.Albuminuria is directly associated with increased plasma PAI-1 and factor Ⅷ levels in NIDDM patients[J].Diabetes Res Clin Pract,1997,36:11-18.
  • 8Kagami S,Kuhara T,Okada K,et al.Dual effects of angiotensin Ⅱ in the plasminogen/plasmin system in rat mesangial cells[J].Kidney Int,1997,51:664-671.
  • 9Motojima M,Kakuchi J,Yoshioka T,et al.Association of TGF-beta singnaling in angiotensin Ⅱ-induced PAI-1 mRNA upregulation in mesangial cells:role of PKC[J].Biochim Biophys Acta,1999,1449:217-226.
  • 10Rovin B H,Doe N,Tan L C,et al. Monocyte chemoattractant protein 1 levels in patients with glomerular disease[J].Am J Kidney Dis,1996,27:640-646.

共引文献41

同被引文献27

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部